Yonghe Medical Group Co (HKSE:02279) Beneish M-Score: -3.03 (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02279 Yonghe Medical Group Co Ltd HKSE:02279
84 GF Score
Price HK$2.49
GF Value HK$2.01
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Yonghe Medical Group Co Beneish M-Score?

Yonghe Medical Group Co HKSE:02279 +5.51% 84 Beneish M-Score is -3.03 as of Aug. 21, 2026. GuruFocus rates HKSE:02279 with a GF Score™ of 84/100 and a GF Value™ of HK$2.01 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 627 Healthcare Providers & Services companies, Yonghe Medical Group Co ranks better than 80.38% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.03 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Yonghe Medical Group Co's Beneish M-Score or its related term are showing as below:

HKSE:02279' s Beneish M-Score Range Over the Past 10 Years
Min: -3.96   Med: -3.02   Max: -2.45
Current: -3.03

During the past 8 years, the highest Beneish M-Score of Yonghe Medical Group Co was -2.45. The lowest was -3.96. And the median was -3.02.


Yonghe Medical Group Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Yonghe Medical Group Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yonghe Medical Group Co Beneish M-Score Chart

Yonghe Medical Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial -2.65 -2.45 -3.01 -3.96 -3.03

Yonghe Medical Group Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -3.96 0.00 -3.03 0.00

HKSE:02279 vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, Yonghe Medical Group Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yonghe Medical Group Co Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Yonghe Medical Group Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Yonghe Medical Group Co's Beneish M-Score falls into.


HKSE:02279
84GF Score
Yonghe Medical Group Co Ltd HKSE:02279
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yonghe Medical Group Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Yonghe Medical Group Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.6845+0.528 * 0.9098+0.404 * 0.8629+0.892 * 1.0369+0.115 * 0.988
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8699+4.679 * -0.24786-0.327 * 0.9156
=-3.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was HK$17 Mil.
Revenue was HK$1,998 Mil.
Gross Profit was HK$1,319 Mil.
Total Current Assets was HK$943 Mil.
Total Assets was HK$1,880 Mil.
Property, Plant and Equipment(Net PPE) was HK$787 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$269 Mil.
Selling, General, & Admin. Expense(SGA) was HK$676 Mil.
Total Current Liabilities was HK$607 Mil.
Long-Term Debt & Capital Lease Obligation was HK$403 Mil.
Net Income was HK$81 Mil.
Gross Profit was HK$0 Mil.
Cash Flow from Operations was HK$547 Mil.
Total Receivables was HK$10 Mil.
Revenue was HK$1,927 Mil.
Gross Profit was HK$1,158 Mil.
Total Current Assets was HK$672 Mil.
Total Assets was HK$1,843 Mil.
Property, Plant and Equipment(Net PPE) was HK$1,000 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$337 Mil.
Selling, General, & Admin. Expense(SGA) was HK$750 Mil.
Total Current Liabilities was HK$583 Mil.
Long-Term Debt & Capital Lease Obligation was HK$498 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(16.606 / 1997.711) / (9.508 / 1926.612)
=0.008313 / 0.004935
=1.6845

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1157.583 / 1926.612) / (1319.304 / 1997.711)
=0.600839 / 0.660408
=0.9098

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (942.887 + 786.965) / 1880.065) / (1 - (672.436 + 999.912) / 1842.994)
=0.079898 / 0.092592
=0.8629

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1997.711 / 1926.612
=1.0369

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(336.541 / (336.541 + 999.912)) / (269.195 / (269.195 + 786.965))
=0.251817 / 0.254881
=0.988

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(676.069 / 1997.711) / (749.553 / 1926.612)
=0.338422 / 0.389052
=0.8699

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((402.639 + 606.828) / 1880.065) / ((498.102 + 582.641) / 1842.994)
=0.536932 / 0.586406
=0.9156

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(81.43 - 0 - 547.423) / 1880.065
=-0.24786

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Yonghe Medical Group Co has a M-score of -3.03 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.03 mean?
Yonghe Medical Group Co (HKSE:02279) has a Beneish M-Score of -3.03 as of Aug. 21, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Yonghe Medical Group Co and its competitors. According to the industry distribution chart, Yonghe Medical Group Co ranks #123 out of 627 companies in the Healthcare Providers & Services industry, placing it in the top 19.6%.
Is Yonghe Medical Group Co's Beneish M-Score too high?
Yonghe Medical Group Co's current Beneish M-Score is -3.03. Based on the distribution chart, Yonghe Medical Group Co ranks #123 out of 627 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Yonghe Medical Group Co has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yonghe Medical Group Co's Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Yonghe Medical Group Co ranks #123 out of 627 companies for Beneish M-Score. This places Yonghe Medical Group Co in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Yonghe Medical Group Co and its competitors. Yonghe Medical Group Co's current Beneish M-Score is -3.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yonghe Medical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Yonghe Medical Group Co (HKSE:02279) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$2.01, compared to a current price of HK$2.49 — trading 23.9% above its estimated fair value. The current Beneish M-Score is -3.03. Yonghe Medical Group Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Yonghe Medical Group Co (HKSE:02279), the current Beneish M-Score is -3.03 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Yonghe Medical Group Co (HKSE:02279) Overvalued in 2026?

Based on GuruFocus' analysis, Yonghe Medical Group Co stock appears to be overvalued. The current stock price of HK$2.49 is trading 23.9% above its estimated GF Value™ of HK$2.01. GuruFocus considers Yonghe Medical Group Co to be Modestly Overvalued.

Key valuation signals for HKSE:02279:

  • Beneish M-Score: -3.03
  • GF Value™: HK$2.01 vs. price of HK$2.49 (23.9% above fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the HKSE:02279 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Yonghe Medical Group Co Business Description

Other Exchanges L97:Germany
Address Office Tower No. 12B, Chaowai Street, 16th Floor, KunTai International Building, Chaoyang District, Beijing, CHN, 100020
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. The company is principally engaged in the provision of hair transplant services. The company generated the majority of its revenue from hair transplant services. The company offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
84GF Score

Get the complete analysis for HKSE:02279

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.49
Price
HK$2.01
GF Value